CME Listings
IDCareLive CME and Board Review Courses
Found 3 listings
Preventing the Preventable with Immunizations
Publisher: IDCareLive
Credit Hours: 2
Credit Type: AMA PRA Category 1
Format: Live Course
Price: Free
Release Date: September 16, 2015 00:00
Expiration Date: 3/16/2016
Summary: At the conclusion of this activity, participants will be able to: Describe recent vaccine-preventable outbreaks in the United States
Regularly assess pediatric and adult patients for immunization status, and advise them about receiving age-appropriate vaccinations according to ACIP recommendations
Identify persons at risk for invasive pneumococcal disease
Describe the efficacy of pneumococcal vaccines in adult patients and their recommendations for use
Categories List: Family Medicine Pediatrics Primary Care
Invasive Mycoses: A High-Risk Battle in the High-Risk Patient
Publisher: IDCareLive
Credit Hours: 2
Credit Type: AMA PRA Category 1
Format: Live Course; Enduring Material
Price: Free
Release Date: October 20, 2015 00:00
Expiration Date: 4/20/2016
Summary: Course Highlights: New weapons in the fight against invasive candida infection
Immunocompromised patients and the changing epidemiology of invasive mycoses
Controversies in empirical treatment in patients with suspected invasive mycoses
Treating invasive fungal infections from a guideline-based algorithmic approach
Challenges with improving outcomes for patients with invasive pulmonary aspergillosis
Mortality associated with mucormycosis
Drug interaction considerations with azole-based therapies
Categories List: Dermatology Infectious Diseases
New Kids on the Block: Antimicrobial Advances in the Management of Gram-Positive Skin Infections
Publisher: IDCareLive
Credit Hours: 1.5
Credit Type: AMA PRA Category 1
Format: Live Course; Enduring Material
Price: Free
Release Date: November 4, 2015 00:00
Expiration Date: 5/4/2016
Summary: Course Highlights: Examine reduced efficacy of vancomycin on MRSA
Consider changing bacterial epidemiology of acute bacterial skin infections
Explore clinical efficacy of oritavancin, dalbavancin, and tedizolid in treating skin infections
Review new antimicrobial drugs with efficacy against MRSA
Categories List: Dermatology Infectious Diseases